Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
All pregnant women who performed an OGTT following Italian Guidelines and then delivered at our University Hospital from march 2020 to march 2021 were prospectively enrolled in this study. Primary outcome of the study was the number of women to whom was diagnosed GDM with only the fasting glucose value (≥ 92 mg/dl), following Italian Diabetes Societies recommendations for COVID 19 pandemic period. In the same time, we prospectively collected the data of women who became diabetic following the criteria of WHO 1999 (fast glucose value ≥ 120 mg/dl, 2 hours later ≥ 140 mg/dl) still in use in some large countries like India. From the clinical charts, we reported the distribution of risk factors for GDM (maternal age ≥ 35 years, family history for diabetes type 2, ethnia, BMI ≥ 25, previous GDM) and clinical outcomes such as hypertensive disorders, preterm birth, macrosomia, intrauterine growth restriction and Caesarean section in emergency.
These data will be compared between the 2 groups consisting in those diagnosed with only IADPSG criteria versus those diagnosed with only WHO '99 criteria.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| IADPSG |
| ||
| WHO '99 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| GDM screening criteria | Procedure | difference in risk factors and clinical outcomes between groups |
|
| Measure | Description | Time Frame |
|---|---|---|
| prevalence of women with a diagnosis of GDM following guidelines during COVID pamdemic | evaluation of fast glucose level in the period recommended for GDM screening following Italian guidelines | from march 2020 to march 2021 |
| Measure | Description | Time Frame |
|---|---|---|
| GDM diagnosis with IADPSG criteria versus WHO '99 criteria | difference in risk factors and clinical outcomes between groups | from March 2020 to March 2021 |
Not provided
Inclusion Criteria: Pregnant women who perform GDM screening -
Exclusion Criteria: Twin pregnancies
-
Not provided
Not provided
All pregnant women who in a 12-month period perform GDM screening and then deliver at our University Hospital
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital | Messina | Italy |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32888369 | Result | van-de-l'Isle Y, Steer PJ, Watt Coote I, Cauldwell M. Impact of changes to national UK Guidance on testing for gestational diabetes screening during a pandemic: a single-centre observational study. BJOG. 2021 Apr;128(5):917-920. doi: 10.1111/1471-0528.16482. Epub 2020 Oct 7. | |
| 36316733 | Derived | D'Anna R, Di Benedetto A, Palella S, Miceli A, Romeo P, Corrado F. Screening of GDM during COVID pandemic in an Italian setting: comparison between IADPSG and WHO '99 criteria. Diabetol Metab Syndr. 2022 Oct 31;14(1):164. doi: 10.1186/s13098-022-00936-4. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided